Dr. Ramalingam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3404 Wake Forest Road
Raleigh, NC 27609
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 2013 - 2016- Duke University HospitalResidency, Internal Medicine, 2010 - 2013
University of North Carolina at Chapel Hill School of MedicineClass of 2010
Certifications & Licensure
NC State Medical License 2010 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Development of a Cabozantinib (Cabometyx) Symptom Management Application for Use in Patients With Renal Cancer Start of enrollment: 2019 Aug 21
Publications & Presentations
PubMed
- 25 citationsProstate-specific antigen response in black and white patients treated with abiraterone acetate for metastatic castrate-resistant prostate cancer.Sundhar Ramalingam, Michael S. Humeniuk, Rachel Hu, Julia Rasmussen, Patrick Healy
Urologic Oncology. 2017-01-23 - 134 citationsReverse-phase protein lysate microarrays for cell signaling analysis.Brett Spurrier, Sundhar Ramalingam, Satoshi Nishizuka
Nature Protocols. 2008-01-01 - 12 citationsMdm2 RING mutation enhances p53 transcriptional activity and p53-p300 interaction.Hilary V. Clegg, Yoko Itahana, Koji Itahana, Sundhar Ramalingam, Yanping Zhang
Plos One. 2012-05-29
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
